COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on: April 10,2024 14

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on:April 10,2024 14

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Updated on: April 12,2024 20

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Updated on:April 12,2024 20

Getting to the bottom of long COVID

Updated on: October 21,2024 0

Getting to the bottom of long COVID

Updated on:October 21,2024 0

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Updated on: March 20,2024 11

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Updated on:March 20,2024 11

Study shows narrative conversion messages boost attitudes about COVID vaccinations among unvaccinated adults

by Mike Krings,University of KansasCredit: CC0 Public DomainPublic health communicators have tried numerous methods to encourage people to accept COVID-19 vaccinations and boosters. And while so

Updated on: March 27,2024 0

Study shows narrative conversion messages boost attitudes about COVID vaccinations among unvaccinated adults

by Mike Krings,University of KansasCredit: CC0 Public DomainPublic health communicators have tried numerous methods to encourage people to accept COVID-19 vaccinations and boosters. And while so

Updated on:March 27,2024 0

Study identifies increase in antibiotic-resistant typhoid

by University of LiverpoolCiprofloxacin-sensitive, DCS, or ciprofloxacin-resistant phenotypes among S Typhi isolated from Queen Elizabeth Central Hospital, by month. Ciprofloxacin susceptibility

Updated on: June 04,2024 6

Study identifies increase in antibiotic-resistant typhoid

by University of LiverpoolCiprofloxacin-sensitive, DCS, or ciprofloxacin-resistant phenotypes among S Typhi isolated from Queen Elizabeth Central Hospital, by month. Ciprofloxacin susceptibility

Updated on:June 04,2024 6

The REAL Killers - Trans Fats

Updated on: September 20,2024 0

The REAL Killers - Trans Fats

Updated on:September 20,2024 0

The Deadliest Virus on Earth

Updated on: August 30,2024 0

The Deadliest Virus on Earth

Updated on:August 30,2024 0

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Updated on: April 01,2024 20

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Updated on:April 01,2024 20

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient

Updated on: April 10,2024 16

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient

Updated on:April 10,2024 16

Study shows promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus

byOregon Health & Science UniversityJonah Sacha, Ph.D., senior co-author of a study published today in the journalNature Communications, says the research could lead to a universal inf

Updated on: August 06,2024 0

Study shows promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus

byOregon Health & Science UniversityJonah Sacha, Ph.D., senior co-author of a study published today in the journalNature Communications, says the research could lead to a universal inf

Updated on:August 06,2024 0

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice

Updated on: April 16,2024 18

ISG15 deficiency linked to antiviral immunity in humans

(HealthDay)—Investigators describe a strategy for development of a broad-spectrum anti-viral agent. Their research was published online May 19 inNature Communications.Noting that studies in mice

Updated on:April 16,2024 18